日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Outcomes of therapy-related non-core binding factor acute myeloid leukemia with venetoclax-based therapies

维奈托克治疗相关非核心结合因子急性髓系白血病的疗效

Senapati, Jayastu; Croden, Jennifer; Garcia-Manero, Guillermo; Takahashi, Koichi; Daver, Naval G; Kadia, Tapan M; Borthakur, Gautam; Short, Nicholas James; Jabbour, Elias; Haddad, Fadi; Marvin-Peek, Jennifer; Abbas, Hussein A; Bose, Prithviraj; Tang, Guilin; Loghavi, Sanam; Shpall, Elizabeth J; Ramdial, Jeremy; Popat, Uday R; Champlin, Richard E; Ravandi, Farhad; Kantarjian, Hagop M; Dinardo, Courtney D

Mini-hyper-CVD plus venetoclax and navitoclax for relapsed/refractory acute lymphoblastic leukemia

微量高剂量化疗联合维奈托克和纳维托克治疗复发/难治性急性淋巴细胞白血病

Short, Nicholas J; Kantarjian, Hagop; Jain, Nitin; Kadia, Tapan M; Senapati, Jayastu; Haddad, Fadi G; Maroun, Manuel M; Sasaki, Koji; Xiao, Lianchun; Huang, Xuelin; Karrar, Omer; Abramova, Regina; Zhao, Min; Garris, Rebecca; Konopleva, Marina; Ravandi, Farhad; Jabbour, Elias

Short-chain fatty acid-producing microbes differentiate non-infectious and infectious neutropenic fever in leukemia

产生短链脂肪酸的微生物可区分白血病中的非感染性和感染性中性粒细胞减少性发热。

Franklin, Samantha; Sahasrabhojane, Pranoti; Hayase, Tomo; Hayase, Eiko; Chang, Chia-Chi; Senapati, Jayastu; Desikan, Sai Prasad; Kadia, Tapan; Lorenzi, Philip L; Jenq, Robert R; Shelburne, Samuel A; Galloway-Peña, Jessica

Advances in Acute Lymphoblastic Leukemia Review Series

急性淋巴细胞白血病进展综述系列

Senapati, Jayastu; Short, Nicholas J

Molecular characterization and predictors of relapse in patients with Ph + ALL after frontline ponatinib and blinatumomab

一线接受帕纳替尼和布林妥莫单抗治疗后,Ph+ ALL 患者的分子特征及复发预测因子

Short, Nicholas J; Kantarjian, Hagop; Furudate, Ken; Jain, Nitin; Ravandi, Farhad; Karrar, Omer; Loghavi, Sanam; Nasr, Lewis; Haddad, Fadi G; Senapati, Jayastu; Garris, Rebecca; Takahashi, Koichi; Jabbour, Elias

A phase 1/2 study of DS-1594 menin inhibitor in relapsed/refractory acute leukemias

DS-1594 menin抑制剂治疗复发/难治性急性白血病的1/2期研究

Senapati, Jayastu; Konopleva, Marina; Issa, Ghayas C; Jabbour, Elias; Kadia, Tapan; DiNardo, Courtney; Borthakur, Gautam; Pemmaraju, Naveen; Short, Nicholas J; Yilmaz, Musa; Deshmukh, Indraneel; Alvarez, Joie; Loghavi, Sanam; Tang, Guilin; Abbas, Hussein A; Andreeff, Michael; Bhalla, Kapil; Midde, Narasimha M; Said, Nabil; Noyalis, Amy; Mires, Derek E; Ning, Jing; Xiao, Lianchun; Ravandi, Farhad; Garcia-Manero, Guillermo; Kantarjian, Hagop M; Daver, Naval G

Azacitidine, Venetoclax, and Magrolimab in Newly Diagnosed and Relapsed Refractory Acute Myeloid Leukemia: Phase Ib/II Study and Correlative Analysis

阿扎胞苷、维奈托克和马格罗利单抗治疗新诊断和复发难治性急性髓系白血病:Ib/II期研究及相关性分析

Daver, Naval; Senapati, Jayastu; Kantarjian, Hagop M; Wang, Bofei; Reville, Patrick K; Loghavi, Sanam; Yilmaz, Musa; DiNardo, Courtney D; Kadia, Tapan M; Yassouf, Mhd Yousuf; Maiti, Abhishek; Arora, Sankalp; Montalban Bravo, Guillermo; Tang, Guilin; Borthakur, Gautam; Sasaki, Koji; Pemmaraju, Naveen; Alvarez, Joie; Nogueras Gonzalez, Graciela M; Ning, Jing; Issa, Ghayas C; Konopleva, Marina; Andreeff, Michael; Ravandi, Farhad; Garcia-Manero, Guillermo; Abbas, Hussein A

Mayo Genetic Risk Models for Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax + Hypomethylating Agent

梅奥诊所针对接受维奈托克联合去甲基化药物治疗的新诊断急性髓系白血病患者的遗传风险模型

Gangat, Naseema; Elbeih, Azeem; Ghosoun, Nour; McCullough, Kristen; Aperna, Fnu; Johnson, Isla M; Abdelmagid, Maymona; Al-Kali, Aref; Alkhateeb, Hassan B; Begna, Kebede H; Elliott, Michelle; Mangaonkar, Abhishek; Matin, Aasiya; Saliba, Antoine N; Hefazi Torghabeh, Mehrdad; Litzow, Mark R; Hogan, William; Shah, Mithun; Patnaik, Mrinal M; Pardanani, Animesh; Badar, Talha; Murthy, Hemant; Foran, James; Palmer, Jeanne; Sproat, Lisa; Khera, Nandita; Arana Yi, Cecilia; Yates, Samuel; Sneider, Abigail; Dworkin, Emily; Patel, Anand A; Bazinet, Alexandre; Senapati, Jayastu; Bataller, Alex; DiNardo, Courtney; Kadia, Tapan; Tefferi, Ayalew

Hyper-CVAD and Sequential Blinatumomab Without and With Inotuzumab in Young Adults With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia

在初诊为费城染色体阴性B细胞急性淋巴细胞白血病的年轻成人患者中,采用Hyper-CVAD方案和序贯Blinatumomab方案(不联合或联合Inotuzumab)治疗。

Kantarjian, Hagop; Short, Nicholas J; Jain, Nitin; Haddad, Fadi G; Kadia, Tapan; Yilmaz, Musa; Ferrajoli, Alessandra; Sasaki, Koji; Alvarado, Yesid; Pemmaraju, Naveen; Senapati, Jayastu; Garris, Rebecca; Ravandi, Farhad; Jabbour, Elias

Outcomes of Patients With Treated Secondary Acute Myeloid Leukemia: A High-Risk Subtype That Warrants an Independent Prognostic Designation

接受治疗的继发性急性髓系白血病患者的预后:一种值得单独列为预后类别的高危亚型

Senapati, Jayastu; Kantarjian, Hagop M; Haddad, Fadi G; Short, Nicholas J; Borthakur, Gautam; Kanagal-Shamanna, Rashmi; Tang, Guilin; Jabbour, Elias; DiNardo, Courtney D; Daver, Naval; Montalban-Bravo, Guillermo; Shah, Vishrut; Alousi, Amin; Shpall, Elizabeth; Popat, Uday; Garcia-Manero, Guillermo; Ravandi, Farhad; Kadia, Tapan M